MENU
Aim higher

TRANSMAL

Translational research services for accelerated discovery of antimalarial drugs

TRANSMAL aims at implementing a commercial, fee-for-service platform for cost-effective evaluation of the efficacy of antimalarial drugs. The development of such treatments is key to meet the goal of global malaria elimination, but hampered by a lack of predictive pre-clinical models with sufficient throughput and level of standardization. TRANSMAL will deliver enabling technology in the form of industrial-quality in vitro and in vivo models to predict the efficacious dose of candidate drugs.
Project ID: 
11 500
Ranking: 
7
Cut-off: 
7
Start date: 
01-11-2017
Project Duration: 
24months
Project costs: 
2 378 750.00€
Technological Area: 
Pharmaceutical Products / Drugs
Market Area: 
Pharmaceuticals/fine chemicals